Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

[Serum uric acid prevalence and changes post various antihypertensive agents in patients with essential hypertension].

Chen H, Yang LQ, Yu L, Wu XY, Lu LH, Gui W.

Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Jun;36(6):523-6. Chinese.

PMID:
19100066
2.

Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.

Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, Black HR, Cohen J, Davis BR, Frost P, Smith W, Gonzalez N, Guthrie GP, Oberman A, Rutan G, Probstfield JL, Stamler J.

Arch Intern Med. 1998 Apr 13;158(7):741-51.

PMID:
9554680
3.
4.

Comparison of antihypertensive and metabolic effects of losartan and losartan in combination with hydrochlorothiazide--a randomized controlled trial.

Owens P, Kelly L, Nallen R, Ryan D, Fitzgerald D, O'Brien E.

J Hypertens. 2000 Mar;18(3):339-45.

PMID:
10726721
5.
6.
7.

Beneficial effect of switching from a combination of angiotensin II receptor blockers other than losartan and thiazides to a fixed dose of losartan/hydrochlorothiazide on uric acid metabolism in hypertensive patients.

Ohshiro K, Sakima A, Nakada S, Kohagura K, Yamazato M, Tana T, Ohya Y.

Clin Exp Hypertens. 2011;33(8):565-70. doi: 10.3109/10641963.2011.577487. Epub 2011 Sep 29.

PMID:
21958001
8.

Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.

de la Sierra A, Gil-Extremera B, Calvo C, Campo C, García-Puig J, Márquez E, Oliván J, Roca Cusachs A, Sanz de Castro S, Pontes C, Delgadillo J.

J Hum Hypertens. 2004 Mar;18(3):215-22.

PMID:
14973517
10.

Long-term effects of losartan and enalapril, alone or with a diuretic, on ambulatory blood pressure and cardiac performance in hypertension: a case-control study.

Verdecchia P, Schillaci G, Reboldi GP, Sacchi N, Bruni B, Benemio G, Porcellati C.

Blood Press Monit. 2000 Jun;5(3):187-93.

PMID:
10915233
11.

Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker.

Ohnishi K, Kohno M, Yukiiri K, Masugata H, Wada Y, Takagi Y, Ohmori K.

Int J Clin Pharmacol Ther. 2001 Oct;39(10):417-22.

PMID:
11680666
12.

Antihypertensive efficacy and safety of fixed-dose combination therapy with losartan plus hydrochlorothiazide in Japanese patients with essential hypertension.

Saruta T, Ogihara T, Matsuoka H, Suzuki H, Toki M, Hirayama Y, Nonaka K, Takahashi K.

Hypertens Res. 2007 Aug;30(8):729-39.

PMID:
17917321
14.

[The effects of angiotensin II receptor blockers in hypertensive patients complicating hyperuricaemia].

Dang AM, Liu GZ, Zhang YH, Chen GL; Intervening Uric Acid Study Group Investigators.

Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Oct;34(10):882-5. Chinese.

PMID:
17217711
15.

Effect of eprosartan and losartan on uric acid metabolism in patients with essential hypertension.

Puig JG, Mateos F, Buño A, Ortega R, Rodriguez F, Dal-Ré R.

J Hypertens. 1999 Jul;17(7):1033-9.

PMID:
10419078
17.

Losartan/hydrochlorothiazide combination vs. high-dose losartan in patients with morning hypertension--a prospective, randomized, open-labeled, parallel-group, multicenter trial.

Ueda T, Kai H, Imaizumi T; MAPPY Study Investigators.

Hypertens Res. 2012 Jul;35(7):708-14. doi: 10.1038/hr.2012.27. Epub 2012 Mar 8.

PMID:
22399096
18.
20.
Items per page

Supplemental Content

Write to the Help Desk